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Background: Ubiquilins are proteins that function as ubiquitin receptors in eukaryotes. Mutations in two
ubiquilin-encoding genes have been linked to the genesis of neurodegenerative diseases. However, ubiquilin
functions are still poorly understood.
Results: In this study, evolutionary and functional data are combined to determine the origin and diversification of
the ubiquilin gene family and to characterize novel potential roles of ubiquilins in mammalian species, including
humans. The analysis of more than six hundred sequences allowed characterizing ubiquilin diversity in all the main
eukaryotic groups. Many organisms (e. g. fungi, many animals) have single ubiquilin genes, but duplications in
animal, plant, alveolate and excavate species are described. Seven different ubiquilins have been detected in
vertebrates. Two of them, here called UBQLN5 and UBQLN6, had not been hitherto described. Significantly,
marsupial and eutherian mammals have the most complex ubiquilin gene families, composed of up to 6 genes.
This exceptional mammalian-specific expansion is the result of the recent emergence of four new genes, three of
them (UBQLN3, UBQLN5 and UBQLNL) with precise testis-specific expression patterns that indicate roles in the
postmeiotic stages of spermatogenesis. A gene with related features has independently arisen in species of the
Drosophila genus. Positive selection acting on some mammalian ubiquilins has been detected.
Conclusions: The ubiquilin gene family is highly conserved in eukaryotes. The infrequent lineage-specific
amplifications observed may be linked to the emergence of novel functions in particular tissues.
Keywords: Ubiquitination, Spermiogenesis, Ubiquitin receptors, Gene duplication, NeurodegenerationBackground
Mutations in the Saccharomyces cerevisiae gene DSK2
were found to be suppressors of temperature-sensitive
mutations in KAR1, a gene involved in duplication of
the yeast spindle pole body [1]. Soon it became clear
that DSK2 was a member of a family of evolutionary
conserved genes, present not only in yeasts but also in
animals and plants, whose protein products are charac-
terized by having a N-terminal ubiquitin-like (UBL) do-
main, an C-terminal ubiquitin-associated (UBA) domain
and a variable number of internal Sti1 repeats [2-6]
These proteins are today commonly known as ubiqui-
lins. Mammals have several ubiquilin genes [4,7-9] Early
studies demonstrated that three of them, called UBQLN1
(formerly known also as PLIC-1), UBQLN2 (a. k. a.
PLIC-2) and UBQLN4 (a. k. a. A1Up, UBIN, CIP75), areCorrespondence: imarin@ibv.csic.es
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unless otherwise stated.widely expressed in human, mouse or rat, while a fourth
one, UBQLN3, is testis-specific in both human and
mouse [4,6,8-12]. A fifth ubiquilin gene, called UBQLNL,
was later detected in humans (first mentioned in [13]).
Ubiquilins are functionallly linked to the ubiquitin-
proteasome system [7,14]. The UBL domain interacts
with the proteasome and also with proteins containing
ubiquitin-interacting motifs (UIMs), while the UBA do-
main serves to interact with polyubiquitinated proteins,
at the same time protecting ubiquilins from proteasomal
degradation [14-20]. UBL and UBA domains can also
mutually interact [21]. These results suggested that ubi-
quilins might function as ubiquitin receptors [22], i. e.
they would contact with ubiquitinated proteins either to
deliver them to the proteasome for degradation or to
make them enter other destruction pathways (e. g. au-
tophagy). This has been shown to be true not only for
ubiquilins, but for proteins with related structures, also
containing UBL and UBA domains, such as yeast Rad23is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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in [23-26]).
Multiple results linked ubiquilins to several neurode-
generative diseases. One of them is Alzheimer’s disease
(reviewed in [27,28]). UBQLN1 interacts with presenilins
[6] and overexpression of either UBQLN1 or UBQLN2
protects presenilins from degradation [6,29]. Also, a par-
ticular polymorphism in a UBQLN1 intron may increase
the risk of suffering Alzheimer’s disease [30-37]. Add-
itional results linking UBQLN1 with the quality control
of Alzheimer’s disease-related proteins have been found
recently [38-40]. Finally, reduced UBQLN1 levels were
found in the brain cortex of Alzheimer’s disease patients
[38]. Drosophila ubiquilin, encoded by the Ubqn (a. k. a.
dUbqln) gene, may have related functions [41,42]. A sec-
ond disease is amyotrophic lateral sclerosis (ALS). Mis-
sense mutations in the proline residues of PXX repeats
present in UBQLN2 were found to cause sex-linked,
dominant ALS, often associated to frontotemporal de-
mentia [43]. Later, additional missense mutations out-
side those repeats were also linked to ALS [44-46]. In
spinal motor neurons, UBQLN2 appears in ubiquitin-
rich protein aggregates typical of ALS, both in patients
with UBQLN2 mutations and in patients lacking those
mutations [43]. UBQLN1 also interacts with TDP-43, a
protein involved in ALS-specific protein aggregates, and
TDP-43 aggregates with either UBQLN1 or UBQLN2 in
cell systems [44-47]. Similar results have been found in
Drosophila [48]. Characteristic ubiquilin-containing ag-
gregates are also found in ALS patients with hexanucleo-
tide expansions in the non-coding region of the C9orf72
gene, which is a common mutation found in both famil-
ial and sporadic ALS [49]. The fact that ubiquilins inter-
act also with proteins involved in spinocerebellar ataxia
type 1 (UBQLN4 with ataxin-1; [9,50]] and Huntington’s
disease (UBLQN1 with huntingtin [51]), that UBLQN1
and UBQLN2 proteins are found in protein aggregates
in Huntington disease models and human brains af-
fected by Huntington and other neurodegenerative dis-
eases [52-54] and the finding of UBQLN1 mutations in
Brown-Vialetto-Van Laere syndrome, a rare neurological
disease [55], further suggested important roles of these
proteins in neural tissues. However, it must be empha-
sized that, no matter how interesting all these results
are, they probably reflect just a small fraction of the
range of ubiquilin functions in humans and other mam-
mals. For example, the broad expression patterns of
UBQLN1, UBQLN2 and UBQLN4 suggest that it is likely
that other tissues or organs, besides the brain, may be
affected by mutations in those genes. It is also significant
that the testis-specific roles of UBLQN3 or the functions
of UBQLNL are totally unknown. For these reasons, to
determine additional roles for members of this family of
proteins is a significant goal.In this study, I analyze the patterns of diversification
of ubiquilin-encoding genes in all eukaryotes, with em-
phasis in mammals, in which it has been found a unique
expansion of this gene family. UBQLN4 turns to be the
oldest among the ubiquilin genes present in humans and
other vertebrates, corresponding to the ancestral gene
present in many other eukaryotes. Vertebrate species
often have quite different numbers of ubiquilin-encoding
genes, due to duplications and losses of these genes in
different lineages. Several of these duplications, occurred
in mammals, have generated a group of genes that are
expressed only in testis. Functional data suggest a post-
meiotic role, in spermiogenesis. These results are the
first comprehensive analysis of the ubiquilin gene family
available and solve the main questions regarding the ori-
gin and diversification of this family in eukaryotes. In
addition, they suggest significant new views of ubiquilin
functional roles.
Results
Global patterns of ubiquilin family evolution
Comprehensive searches, summarized in the Methods
section, determined the presence in the databases of 643
full-length or almost complete ubiquilin sequences, all
of them derived from eukaryotic species. So far already
described in animals, plants and fungi [2,4,6], the ancient
origin of this family of proteins is confirmed by the fact
that they can be detected in most eukaryotic groups.
They are present in both unikonts such as animals,
fungi, amoebozoans, choanoflagellates or ichthyospor-
eans and bikonts such as plants, alveolates, strameno-
piles or excavates. The presence of multiple ubiquilin
genes was detected both in some plant and in some ani-
mal species. Given that organisms belonging to the sister
groups of plants (green algae) and the sister group of an-
imals (choanoflagellates) have single ubiquilin genes, it
seemed likely that the expansion of the ubiquilin family
in the lineages that gave rise to those plants or animals
with multiple genes occurred relatively recently. This in-
teresting question will be examined in more detail in the
next Sections. A single ubiquilin gene was also found in
127 fungal species. The only fungus for which two se-
quences were detected was Batrachochytrium dendroba-
tidis (Chytridiomycota). However, while one of the
sequences resembles the rest of fungal ubiquilins, the
other one (accession number GL882891.1) encodes for a
ubiquilin protein which is extremely different from the
other fungal ubiquilins, moreover not resembling any
other sequence in our database. Assuming it is not just a
sequencing artifact, how this gene originated, i. e.
whether simply emerged in a Batrachochytrium-specific
duplication followed by drastic sequence changes or,
perhaps, by horizontal transmission from another, un-
known organism, is uncertain. Finally, two very different
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alveolates, another result that will be described in more
detail below.
An alignment of the 643 sequences was obtained
(available as Additional file 1) and I performed phylo-
genetic analyses, either based on full-length sequences
or only in the highly conserved UBL and UBA se-
quences. In general, the second type of analysis must be
preferred when the goal is to compare very different ubi-
quilins. The reason is that ubiquilin sequences have a
variable number of Sti1 repeats, in a way that is often
unrelated to the phylogenetic proximity among species.
This is an important problem if the full-length se-
quences are used for phylogenetic reconstruction, be-
cause the presence of exactly the same number of
repeats may cause a spurious, convergent similarity
among very distant sequences. However, whenever all
sequences have the same structure (e. g. plants, see
below), the full-length sequences can be safely used, thus
increasing the amount of useful information.
In Figure 1, a compact view of the trees based on the
UBL and UBA domains is shown (the whole, expanded
view, including species names and accession numbers
can be found as Additional file 2). The results suggested
that the sequences present in animals, higher plants and
fungi have a monophyletic origin, given that they appear
together, as three independent groups, in those trees.
The only apparent exceptions are a few Drosophila-spe-
cific duplicates that will be discussed below and the
already mentioned Batrachochytrium sequence. It is true
that these monophyletic origins are not fully demon-
strated by the analyses, given that bootstrap support for
the corresponding branches is low (Figure 1, Additional
file 2). However, this was not unexpected, given the lim-
ited phylogenetic signal provided by the sequences of
the UBL and UBA domains, which, together, have just
around 120 amino acids. In any case, alternative hypoth-
eses, based on multiple origins, are technically possible
but clearly implausible given the available data. Along
the next sections, all new evidence presented is, as will
become apparent, fully coherent with these hypothesized
monophyletic origins.
Diversification of ubiquilin genes in animal species
Figures 2 and 3 summarize the results for all animal spe-
cies for which ubiquilin sequences have been found.
Figure 2 details phylogenetic trees, derived again from
the sequences of the UBL and UBA domains, summariz-
ing the relationships among 349 animal ubiquilins. It
turned out that many animal species have single ubiqui-
lin genes. More precisely, I found that only vertebrates
and (as it was shown already in Figure 1) species of the
Drosophila genus have two or more. As indicated above,
the choanoflagellate Monosiga brevicollis, which is theclosest animal relative among all protozoans for which
data are available, also has a single ubiquilin gene. Thus,
it is likely that only one gene of this family was present
when animals originated.
The peculiar Drosophila results can be explained quite
simply. One of the Drosophila species ubiquilin genes
(called Ubqn) is typical, i. e. very similar to those found
in all other insects (Figure 2). This gene has been the
one examined in previous functional papers using D.
melanogaster as a model [41,42,56]. The second Dros-
ophila gene (named CG31528) clearly corresponds to a
highly divergent but recently emerged, genus-specific
duplicate. According to data compiled in FlyBase (www.
flybase.org), Ubqn has high levels of expression in mul-
tiple tissues, while CG31528 is highly expressed only in
male testis.
A more complex situation is detected in vertebrates.
Results indicate that most vertebrate sequences fit into
five main classes with good bootstrap support. This is
shown in Figure 3, which is simply the section of the
tree shown in Figure 2 that corresponds to the verte-
brate sequences, expanded. From top to bottom, the first
class, indicated as “UBQLN1/2 genes” in Figure 3, in-
cludes two human genes, UBQLN1 and UBQLN2, and
their orthologs, which are present in all other verte-
brates except actinopterygians. The second corresponds
to the set of UBQLN4 orthologs, which appear in the
tree as close relatives of the UBQLN1/2 genes. The third
one surprisingly corresponds to a hitherto undescribed
ubiquilin gene. Probably, the reason for not having been
detected as such before is that it is present in many
mammals, but not in humans. I have called that gene
UBQLN5. Finally, the fourth and fifth correspond to the
two remnant known ubiquilin genes, UBQLNL and
UBQLN3. Only a few reptilian and bird sequences are so
highly divergent that do not fit well in any of those five
main classes. They may correspond to a sauropsid-
specific duplicate, conserved in just a handful of the spe-
cies for which data are currently available (bottom of
Figure 3). That kind of genes can be named UBQLN6.
As indicated in Figure 3, not all genes are detected in
all vertebrates. On the contrary, only a single gene, cor-
responding to the UBQLN4 class, was detected in all
main types of vertebrates, including several actinoptery-
gian fish species, such as Danio rerio or Salmo salar,
which have this single ubiquilin gene. When we examine
a closer relative of humans, the sarcopterygian Latimeria
chalumnae (coelacanth), two genes can already be de-
tected; one of them a typical UBQLN4 and the second
one belonging to the UBQLN1/2 class. This situation,
with two genes, is also found in amphibians, (e. g. Xen-
opus), and birds (e. g. Gallus). In mammals, additional
gene amplifications are observed, with one exception,
namely the monotreme Ornithorhynchus anatinus. Only
Figure 1 Summary tree indicating the distribution of ubiquilins in eukaryotes. This is the neighbor-joining (NJ) tree, but the maximum-
parsimony (MP) and maximum-likelihood (ML) dendrograms were similar enough as to allow all the results to be drawn together. The tree is
drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. A scale bar is
shown below the tree. The numbers in the branches indicate bootstrap supports (in percentages) for the three methods of phylogenetic recon-
struction (as follows: NJ/MP/ML). For simplicity, only the most relevant boostrap values are indicated. In brackets, the number of sequences within
each group. These groups were made by putting together all the sequences that belonged to related species, in order to deduce the minimum
number of groups for each eukaryotic class. Thus, all plant can be put in a single group, animal sequences can be classified into two groups, etc.
For alveolates, stramenopiles and excavates, the main phyla that can be found within each group are indicated (in parentheses). A more detailed
view of this tree can be found in Additional file 2.
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Figure 2 Animal ubiquilins. Bootstrap support (NJ/MP/ML) and number of sequences per group (in brackets) as in Figure 1. Bootstrap values
are shown only for internal branches with consistent support. Scale bar as in Figure 1.
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Figure 3 Classification of vertebrate ubiquilins. This figure corresponds to the subtree indicated as a triangle labelled “Vertebrates” in Figure 2,
which has been expanded here, to show all the main types of ubiquilins. In brackets, the number of sequences in each group and the different
types of vertebrates that have each ubiquilin gene. Bootstrap support (NJ/MP/ML) as in previous figures. Scale bar as in Figure 1.
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nus, namely a UBQLN1/2 gene and a typical UBQLNL
gene. These results indicate when UBQLNL may have
originated after the split which separated the mamma-
lian ancestors from the rest of vertebrates. They also
suggest that UBQLN4 (which is present in species of all
vertebrate groups) have been lost in O. anatinus. In mar-
supials, such as Sarcophilus harrisii or Monodelphis
domestica, five ubiquilin genes (UBQLN1/2, UBQLN3,
UBQLN4, UBQLNL and UBQLN5) were detected. On
the other hand, most eutherians have six: UBLQN1,
UBQLN2, UBQLN3, UBQLN4, UBQLNL and UBQLN5.
Given that the presence of the two different genes,
UBQLN1 and UBQLN2, is restricted to this lineage, it
means that they derive from a recent, eutherian-specific
duplication of the precursor UBQLN1/2 gene present in
other vertebrates. Finally, as I have already indicated,
UBQLN5 – which most likely emerged after the split
that separated monotremes from the rest of mammals,
given its presence in both marsupials and eutherians –
has been lost in some primates. More specifically,UBQLN5 is found in the genomes of prosimians, such as
Otolemur garnettii or Microcebus murinus. However, it
has not been detected either in platyrrhines or in catar-
rhines, including our own species. All these results, put
together, indicate that vertebrates have increased their
number of ubiquilin genes from a single original one
(which would correspond to UBQLN4) to up to 6 genes,
as found today in many mammals.
Analyses of the genomic locations of these genes in
multiple organisms were performed at the Ensembl web
page (see Methods) and provided significant comple-
mentary information to understand their diversification
in vertebrates. I first analyzed the mouse genome, find-
ing the significant result, confirmed later in other spe-
cies, that UBQLNL, UBQLN3 and UBQLN5 are located
in tandem. This indicates that these three genes are evo-
lutionary closely related, being the most likely that
UBQLN3 and UBQLN5, exclusive of marsupials and eu-
therian mammals, emerged by tandem duplications of
UBQLNL, which is the only one detected also in mono-
tremes. I will call from now on these three genes as the
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is that the ortholog of one of the genes adjacent to
UBQLN4 in the mouse genome, called Lamtor2, is also
adjacent to the putative UBQLN4 gene of Danio rerio.
This is additional evidence supporting the conclusions
obtained from the phylogenetic reconstructions, indicat-
ing that all the genes that I have been hitherto calling
UBQLN4 are true orthologs and that the first UBQLN4
gene originated before the split of actinopterygians and
the rest of vertebrates. The third interesting result indi-
cates that UBQLN2 originated from UBQLN1. This de-
rives from the study of the Latimeria genome. It turns
out that the two coelacanth genes, which I defined above
as UBQLN4 and UBQLN1/2 are adjacent in the genome
to, respectively, Lamtor2 (as expected, again confirming
the ancient origin of UBQLN4) and Idnk. Given that this
Idnk gene is in other mammals just adjacent to UBQLN1
(e. g. in mouse, they are both together in chromosome
13), but not adjacent to UBQLN2 (which is X-linked),
we can conclude that the Latimeria gene named so far
UBQLN1/2 most likely corresponds to UBQLN1, with
UBQLN2 being thus an eutherian-specific duplicate.
Additional confirmation is obtained from the fact that,
in other species in which a single UBQLN1/2 gene is
present (e. g. Gallus gallus), that gene is also adjacent to
the Idnk ortholog.
A final type of information which is relevant here con-
cerns the protein domain structure of animal ubiquilins.
As indicated in the Introduction, in addition to the ter-
minal UBL and UBA domains, ubiquilin typically have
one to a few Sti1 domains. I have explored the structures
of all these proteins using the integrated tool InterProS-
can (see Methods). The conclusion is that UBQLN1,
UBQLN2 and UBQLN4 proteins are very similar,Figure 4 Most parsimonious hypothesis to explain the diversification
Rectangle: gene loss. A single gene, which would be orthologous to vertebtypically having 4 Sti1 domains (although less than four
are detected in some cases), while UBQLNL proteins
generally have 2 Sti1 domains and UBQLN3 and
UBQLN5 usually a single one, being the Sti1 domains in
UBQLN3 proteins particularly divergent. Examining
then invertebrate animal proteins, it was observed that
almost all have 4 Sti1 domains, being thus structurally
more similar to UBQLN1, UBQLN2 and UBQLN4 than
to the proteins of the UBQLNL group. Given that we
have deduced that UBQLN4 is the oldest vertebrate
gene, this coincidence is not surprising, and provides
additional evidence supporting the monophyly of all ani-
mal ubiquilins.
Taken all these results together, it is possible to formu-
late the most parsimonious hypothesis that explains the
whole pattern of diversification observed in vertebrates,
which is detailed in Figure 4. It is important that this hy-
pothesis agrees perfectly with all the available informa-
tion (phylogenetic reconstructions, genomic evidence
and protein structure results). According to those data,
from a single ancient vertebrate ubiquilin gene,
UBQLN4, which would be orthologous to the only one
present in non-vertebrate animals, we deduce the early
generation of a first duplicate, UBQLN1, followed by the
origination after the mammalia/sauropsida split of four
additional mammalian-specific ubiquilin genes (first
UBQLNL and later UBQLN2 as a UBQLN1 duplicate,
and UBQLN3 and UBQLN5, which both derive from
UBQLNL) and of the birth of a seventh gene, UBQLN6
in sauropsids. The evidence for an exceptional
mammalian-specific increase in the number of ubiquilin
genes is very robust, given the already extensive data for
these species groups currently present in our databases.
It is interesting to point out here the fact that the threeof the ubiquilin genes in animals. Arrow: origin of a new gene.
rate UBQLN4 was present when animals emerged.
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human neurodegenerative diseases, either potential or
direct (UBQLN1, UBQLN2 and UBQLN4, see Introduc-
tion) have very similar UBA and UBL domains (see the
small distances among them in Figure 3), encode struc-
turally identical proteins and are related by successive
duplications (UBQLN4 ➔ UBQLN1 ➔ UBQLN2). Their
close relationships make advisable to call these three
genes as “UBQLN4 group”. The genes of the UBQLNL
group (UBQLNL, UBQLN3 and UBQLN5) have not so
far been functionally linked to any human disease.
Evolution of ubiquilins in other organisms
In this section, I will first describe the results for the Viri-
diplantae, excluding the chlorophytes, which have highly
divergent ubiquilins (Figure 1). The only relevant informa-
tion obtained from chlorophyte sequences is that a single
gene was found in seven different species and that the
proteins encoded by those genes have 3 or 4 Sti1 repeats.
The number of ubiquilin sequences available in green
plants is limited, just 73, but the broad phylogenetic
range of species from which they derive allow for a pre-
cise characterization of their patterns of diversification.
A first result is that all the species for which there is
complete or almost complete genomic data have a very
limited number of ubiquilins. The maximum number
observed is four, in the dicots Glycine max and Brassica
rapa and the monocot Zea mays. Most species have
however just two ubiquilin genes. Figure 5 shows the
phylogenetic tree obtained when those 73 sequences are
compared, which serves to determine the origin of all
those genes. Contrary to the trees in Figures 1, 2 and 3,
which, as indicated, derive solely from the UBL and
UBA domain information, this tree was obtained with
the full sequences. The reason is that all plants have
structurally very similar ubiquilins, all of them with four
Sti1 domains. Given that they can be quite easily aligned
along their whole lengths, it makes sense using here all
the information to generate the trees. Notice also that
this structural similarity also supports the monophyletic
origin of all plant ubiquilins. This putative monophyly is
again reinforced by the phylogenetic trees (Figure 5),
which perfectly recapitulate the known evolutionary re-
lationships of the plant species, with early-branching
species (such as the charophyte alga Klebsormidium, the
spikemoss Selaginella and the moss Physcomytrella) sep-
arated from both the two gymnosperms for which ubi-
quilin genes have been detected (Picea glauca and
Pseudotsuga menziessi) and all the angiosperms. Within
angiosperms, the divergence of monocot and dicot spe-
cies is also recapitulated in the tree.
The simplest explanation for the results obtained is
that a single ubiquilin gene was present when viridiplan-
tae originated. After that, a few independent duplicationshave occurred in many lineages. Considering that the
evolutionary history of many of these plants has involved
multiple rounds of genome duplication, some of them
ancient, it is significant that only two old duplications
can be deduced from Figure 5. One of them is, which is
highly supported by bootstrap analyses, is observed in
the poaceae (see “Poaceae I” and “Poaceae II” in
Figure 5). The second one is a duplication in dicots, pro-
duced before the splits that separated asterids (see
Lactuca species), rosids (e. g. Arabidopsis) and saxifra-
gales (see the two Paeonia genes). This second duplica-
tion, indicated as “Dicot I” and “Dicot II” in Figure 5, has
a more limited bootstrap support, but it is the simplest
way to reconcile the observed tree with the known phylo-
genetic relationships among all these dicot species. All
the other increases in the number of ubiquilin genes that
have been observed in plants can be explained by inde-
pendent, very recent duplications. Notice for example the
two almost identical ubiquilins found in Selaginella or
the three similar ubiquilins found in Physcomitrella. The
same occurs in many other species, such as Arabidopsis
thaliana, in which there are two very similar ubiquilin
genes (called Dsk2A/At2g17190 and Dsk2B/At2g17200),
which are located in tandem. The species with four
ubiquilin genes (Glycine max, Brassica rapa, Zea mays)
obtained that number also due to recent duplications,
not observed in close relatives (as can be easily deduced
from Figure 5).
Compared with the relatively complex evolutionary
patterns described in vertebrate animals and in plants,
the rest is much simpler, given that multiplications of
the genes of this family are not detected in any other or-
ganism for which data are available. First, a single ubi-
quilin gene has been detected in all the remnant
opisthokonts analyzed. This includes the fungal species,
a choanoflagellate (Monosiga brevicollis) and an icthyos-
porean (Capsaspora owczarzaki). Single genes were also
found in 5 amoebozoan species (from the genera
Entamoeba, Dictyostelium and Polysphondylium). Also, a
single gene has been detected in all stramenopile species
characterized so far. Alveolates for which data are avail-
able have 1 or 2 ubiquilins. In species with two genes
(e. g. which belong to the apicomplexan genera
Plasmodium, Cryptosporidium or Neospora), it is clear
that they are highly divergent, appearing in two distant
groups in the general trees (see details in Additional file
2). This result suggests that they may derive from
ancient duplications. Also, 1–2 genes are detected in
excavate species, duplicates being detected in Trypano-
soma and Leishmania species.
Functional data for mammalian ubiquilins
The results in the previous two sections established that
the rapid amplification of the ubiquilin gene family
Figure 5 Plant ubiquilins. Two ancient duplications are indicated as Dicot I/II and Poaceae I/II (see text). Colors are applied to some main
angiosperm classes (pink: rosid dicots; green: saxifragal dicots; yellow: asterid dicots; blue: monocots).
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eukaryotic lineage. We may now ask for the potential
roles of this novel ubiquilins that may contribute to ex-
plain such amplification. I decided to explore the avail-
able human and mouse expression data to obtain
information about the potential functional roles of each
ubiquilin in vertebrates. Tables 1 and Figures 6 and 7
summarize the expression data for multiple organs, tis-
sues or cell types in, respectively, normal mice and
humans. They were obtained from the last version of the
Gene Atlas database available at BioGPS [57]. In Table 1
(left), I have included the details of the five mouse sam-
ples (tissues, organs or cell types) that had either the
highest or the lowest levels of expression for UBQLN1,
UBQLN2 and UBLQN4. For the other three ubiquilin
genes present in mouse (UBQLN3, UBQLN5 and
UBQLNL), only the five samples with the highest levels
of expression are indicated, given that the values in most
other samples are effectively not different from zero.
The same is done for human ubiquilin genes on the
right panels of Table 1. No data are indicated for
UBQLN5 given that it is absent in our species.
The results shown in Table 1 and Figure 6 comple-
ment what was known about ubiquilin expression in
mouse, adding some interesting new information. First,
these results confirm Northern blot expression data for
mouse UBQLN1-4 [4,8,12] which indicated that the
genes of the UBQLN4 group, UBQLN1, UBQLN2 and
UBQLN4, are expressed in multiple tissues and UBQLN3
is testis-specific. Second, it was found that UBQLNL and
UBLQN5 are also testis-specific (Table 1). Thus, the
three UBQLNL group genes are not only evolutionarily
but also functionally related. Third, it turned out that
the lowest level of expression of both UBQLN1 and
UBQLN2 among all samples analyzed actually corre-
sponds also to the male testis (Table 1). This is not the
case for UBQLN4: “testis” does not appear in the section
of Table 1 corresponding to that gene because the level
of expression in that organ (263.24) was very similar to
the average level for the whole set of samples (309.12 ±
19.63; Table 1). Actually, the low standard error of the
mean of UBQLN4 values indicates a similar expression
in all tissues, including testis.
Additional useful information can be obtained from
Figure 6. By adding together in a single column the
values of expression for all ubiquilin genes in a given tis-
sue, some patterns become evident. Dominant in
Figure 6 are the orange and brown segments, which re-
spectively correspond to UBQLN1 and UBQLN2. These
two have by far the highest levels of expression among all
ubiquilin genes in most tissues. The consistent but quite
low expression of UBQLN4 is, by comparison, dwarfed. It
is also easily noticeable in Figure 6 how radically different
from the rest of samples is the one corresponding to thetestis, in which the UBQLNL group genes account for
most of the expression detected. Among the genes of the
UBQLN4 group, only UBQLN1 has a relatively high level
of expression in testis. Finally, it can be also appreciated in
that figure that many among the samples with the highest
total levels of expression, obtained adding together all ubi-
quilin genes, come from the nervous system (see e. g.
hypothalamus, cerebral cortex, cerebellum, etc.) in good
agreement with previous data [6,11].
Considering now human ubiquilins, it is important
first to notice that the available information is a priori
somewhat less convincing than the data for mouse
genes, given that the levels of expression observed for
all genes are much lower and therefore are closer to
background levels (Table 1, right panels). Even with that
caveat, the fact is that results very similar to those found
in mouse are observed for UBQLN2 (i. e. a broad
pattern of expression, with high level in nervous system
samples and low levels in testis) and UBLQN3 (testis-
specific expression, which is confirmed also by inde-
pendent results [8]). The highest values for UBQLNL
are also found in testis, although here the specificity is
not as high as in mouse. Finally, some of the results for
UBQLN1 are UBQLN4 are somewhat incongruent with
those found in mouse. On one hand, UBQLN1 is
broadly expressed, but no particularly low expression in
testis in detected (this is clearly seen in Figure 7). This
is probably a real result, given that a relatively high level
of expression in testis was observed before [11]. On the
other hand, expression in whole brain samples for
UBQLN4 appears as one of the lowest. However, the
values of UBLQN4 are, as those for UBLQNL just men-
tioned, so low in all samples that is unclear to what
point they are reliable. Actually, other experiments
showed a relatively high level of expression of UBLQN4
in brain [9]. In any case, even with these differences,
both the obvious uniqueness of the patterns of expres-
sion observed in the testis and the fact that several ner-
vous system samples are among the ones with the
highest levels of expression, are two general results de-
tected in both mouse and human (Figures 6 and 7).
The discovery that the UBQLNL group gens are testis-
specific deserves more detailed explorations. Several
works have examined how gene expression changes in
mouse testis after birth. Given that meiosis starts in the
mouse about 10 days post partum, it is possible to indir-
ectly assess whether testis-specific genes may be in-
volved in pre- or postmeiotic roles by analyzing the first
wave of mouse spermatogenesis, which is highly syn-
chronic. Figure 8 summarizes results from three studies
[58-60]. Although the first two are based on expression
microarrays and the third one on deep transcriptome se-
quencing, the results coincide, and also agree well with
those shown before in Figure 6. A summary is as follows:
Table 1 Expression patterns of mouse and human ubiquilin genes, in arbitrary units
MOUSE GENES Expression levels HUMAN GENES Expression levels
UBQLN1 (1424368_s_at) UBQLN1 (gnf1h00141_at)
Cerebellum 5753.64 Bronchial Epithelial Cells 93.95
Hypothalamus 5712.50 CD105+ Endothelial 90.70
Liver 5445.97 CD34+ 89.30
Spinal cord 5357.54 CD56+ NK Cells 87.15
Prostate 5298.15 CD33+ Myeloid 87.05
Mast cells IgE + antigen 1hr 1166.39 Cardiac Myocytes 43.50
Granulocytes mac1 + gr1+ 1052.30 Liver 42.30
Mast cells IgE 901.12 Kidney 39.60
Eyecup 809.26 Adrenal gland 38.75
Testis 691.16 Heart 38.70
Average ± s. e. m. 2651.98 ± 123.15 Average ± s. e. m. 57.58 ± 1.24
UBQLN2 (1450021_at) UBQLN2 (215884_s_at)
Hypothalamus 13657.53 Pineal day 431.56
Nucleus accumbens 12879.57 Pineal night 394.20
Cerebral cortex prefrontal 12305.85 Prefrontal Cortex 367.45
Min6 11411.00 CD4+ Tcells 294.45
Cerebral cortex 11112.89 Wholebrain 284.80
Thymocyte SP CD4+ 538.02 Testis 8.85
B-cells marginal zone 490.66 Testis Intersitial 8.15
Cornea 450.91 Dorsal Root Ganglion 6.95
Granulocytes mac1 + gr1+ 379.54 Testis Leydig Cell 6.45
Testis 318.75 Testis Seminiferous Tubule 5.95
Average ± s. e. m. 3071.72 ± 336.37 Average ± s. e. m. 78.22 ± 10.35
UBQLN4 (1448691_at) UBQLN4 (222252_x_at)
Skeletal muscle 854.12 Prostate 14.30
Embryonic stem line Bruce4 p13 803.26 Pineal day 11.72
Cerebral cortex prefrontal 803.07 Superior Cervical Ganglion 11.10
Embryonic stem line V26 2 p16 800.68 Pons 10.75
Olfactory bulb 776.78 Pineal night 10.58
Osteoblast day14 106.14 Kidney 5.55
Osteoblast day21 94.19 Leukemia lymphoblastic (MOLT-4) 5.50
Granulocytes mac1 + gr1+ 93.57 Salivary gland 5.40
C3H 10T1 2 89.81 Wholebrain 5.15
Macrophage bone marrow 6hr LPS 69.24 Ovary 4.70
Average ± s. e. m. 309.12 ± 19.63 Average ± s. e. m. 7.39 ± 0.18
UBQLN3 (1436903_at) UBQLN3 (220422_at)
Testis 7940.33 Testis Intersitial 565.30
Pancreas 30.80 Testis 406.65
Cerebral cortex prefrontal 11.62 Testis Germ Cell 359.30
Salivary gland 8.30 Testis Seminiferous Tubule 216.90
MEF 6.76 Testis Leydig Cell 206.20
Average ± s. e. m. 87.92 ± 83.09 Average ± s. e. m. 23.80 ± 9.76
UBQLN5 (1453516_at) UBQLN5 Not present in humans
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Table 1 Expression patterns of mouse and human ubiquilin genes, in arbitrary units (Continued)
Testis 696.05
Lacrimal gland 6.10
Embryonic stem line Bruce4 p13 5.90
NK cells 5.62
Mast cells 5.49
Average ± s. e. m. 11.93 ± 7.24
UBQLNL (1437955_at) UBQLNL (gnf1h09806_at)
Testis 2020.45 Testis Intersitial 14.35
Granulocytes mac1 + gr1+ 19.21 Testis 13.40
Cornea 10.63 Leukemia promyelocytic-HL-60 12.30
Microglia 9.19 Cerebellum 11.50
T-cells foxP3+ 7.76 Adrenal Cortex 11.05
Average ± s. e. m. 26.14 ± 21.10 Average ± s. e. m. 7.56 ± 0.15
Data from the BioGPS database. In parenthesis, probes analyzed for each gene.
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sion in testis, from birth to adult mouse. This agrees
with the data shown above in Figure 6 and also with a
report indicating potential roles of UBQLN1 in sperm-
atogenesis [61]; 2) UBQLN2 and UBQLN4 are expressed
at very low/null levels in testis (actually, the background
levels observed are equivalent to those found for genes
considered not expressed at all in that tissue [58,59]); 3)
As already detected in the global results shown above
(Table 1 and Figure 6), the three UBQLNL group genes
are consistently expressed in the testis, with UBQLN3
having the highest expression in the only study in which
all of them were examined [60]; finally, 4) The expres-
sion of the UBQLNL group genes starts only after 20
days post partum, indicating that their products may
have postmeiotic roles.
More precise assesment of those potential roles are
provided by experiments devised to determine gene
expression in particular cell types present in the testis.
Figure 9 (top panel) shows microarray results measuring
expression of ubiquilin genes in different cell types,
seminiferous tubules and whole testis of the mouse [62].
In good agreement with the results presented above, ex-
pression of UBQLNL group genes is high in postmeiotic
spermatids, but low or absent in spermatocytes, sperm-
atogonia or somatic Sertoli cells. Actually, it is possible
that the low level of expression detected for those genes
in spermatocytes is due to contaminants, given that the
authors describe the sample as “82.5% pure”. In any
case, these results agree well with postmeiotic roles, in
spermiogenesis, for the UBQLNL group genes. Results
for human samples [62] are similar (Figure 9B). The
relative lower levels in seminifeous tubules or whole
testis when compared with mouse (Figure 9A) or with
their own levels of expression in spermatids, may be
due to an age-associated low content of postmeioticgerm line cells in the human individuals from which the
samples were obtained, given that they were on average
77 years old.
Test for positive selection acting on human ubiquilin
genes
I checked whether positive selection was detectable on
the sequences of human ubiquilin genes following stand-
ard procedures. First, the conserved UBL and UBA
domains of the five human genes (UBQLN1, UBQLN2,
UBQLN3, UBQLN4 and UBQLNL) and their rat ortho-
logs were aligned. The phylogenetic trees that these
sequences generated were of course congruent with the
expectations derived from Figure 4: UBQLN4 may corres-
pond to the oldest gene, while UBQLN1 and UBQLN2 is a
relatively recent couple of paralogs and UBQLNL and
UBQLN3, a second paralog duo (Figure 10). From the
protein sequences of the UBL and UBA domains of those
10 genes, I obtained the corresponding nucleotide se-
quences and then performed codon-based analyses for
positive selection using the CODEML program of the
PAML package [63,64] and references therein]. Analyses
were made using a recently generated graphical interface
for PAML, called PAMLX [65].
Significant positive selection acting on particular co-
dons in the whole set of sequences was not detected.
Analyses implementing the six main site models imple-
mented in PAML (called M0, M1a, M2a, M3, M7 and
M8; see [63,64]) failed to show any result compatible
with a positive selection regime. In particular, the critical
comparisons [63] involving either the M1a and M2a
models or the M7 and the M8 models were non-
significant (not shown). On the other hand, branch
models [63], which aim to detect positive selection acting
on particular genes or gene lineages, showed more
interesting results. When the simplest M0 model, which
Figure 6 Ubiquilin gene expression in different organs, tissues or cell types of wild-type mice. Data, in arbitrary expression units, obtained
from the BioGPS database [57]. The key names of the samples used in BioGPS are indicated. Although most names are autoexplicative, additional
details of these samples can be found at http://www.biogps.org. Notice the qualitative difference found for testis respect to the other samples. In
testis, most of the expression observed derives from UBQLNL group genes (UBQLN3, UBQLN5, UBQLNL) which are not expressed, or at very low
levels, in all other tissues.
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Figure 7 Expression of ubiquilins in normal human tissues, organs or cell types. Data also from BioGPS. Again, all testis-derived samples
show a very high level of expression of UBQLNL group genes (UBQLN3 and UBQLNL; UBQLN5 is absent in humans).
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Figure 8 Expression of ubiquilin genes in mouse testis, at different days post partum. Data, in arbitrary expression units, derived from
Schultz et al. [58] (Panel A), Shima et al. [59] (Panel B) and Laiho et al. [60] (Panel C).
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dN/dS, i. e., the ratio of the nonsynonymous (dN) to the
synonymous (dS) nucleotide substitution rates per codon
– was compared with a “free-ratio” model in which eachbranch of the tree is allowed to have a different ω value,
it was found that the latter significantly improved over
the first one (2 Δl = 50.53; degrees of freedom = 16; p =
0.00002; see Methods for these parameters). In the free-
Figure 9 Expression of ubiquilin genes in particular testis samples in mouse (Panel A) and human (B). Data from Chalmel et al. [62], again
in arbitrary expression units.
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tion, were observed in four particular branches (labelled
1–4 in Figure 10). It is often convenient to test whether
the free-ratio model, which is parameter rich, can be
simplified, using models in which ω values are allowedFigure 10 Dendrogram corresponding to the five human ubiquilin ge
the sequences. The tree shown here was obtained with the NJ method, bu
1–4 are those in which potential positive selection (ω > 1) was detected in
models [63] tested are also indicated. See text for details.to vary only in a few particular branches. Here, two of
those simpler models were tested. The first was a “five-
ratio” model in which the four potentially interesting
branches detected in the free-ratio model were allowed
to have their own ω values, while a fifth identical valuenes and their orthologs in rat. In parenthesis, accession numbers of
t ML and MP analyses generated exactly the same topology. Branches
PAML analyses. The observed ω values in the three different branch
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ratio model significantly improved over M0, the free-
ratio model was still however better (2 Δl = 22.73;
degrees of freedom = 12; p = 0.029). However, it was ob-
served that only two branches (labelled 3 and 4 in
Figure 4) showed values ω > 1 in the five-ratio model,
which led to the idea of testing a third, “three-ratio”
model, in which only three ω values were allowed, one
for branch 3, another for branch 4 and a third for the
rest of branches of the tree. Again, this three-ratio
model significantly improved over the M0 model, but
was worse than the free-ratio model, albeit with a differ-
ence that was very close to the significance level (2 Δl =
24.48; degrees of freedom = 14; p = 0.041). The ω = 999
values found in some branches in the five-ratio and
three-ratio models imply a very low/zero dS value. Actu-
ally, dS values were 0.0001 in branch 4 of both the five-
ratio and the three-ratio models and 0 in branch 3 of
the three-ratio model. These very low dS values however
do not affect the likelihood comparisons, and therefore,
the conclusion that the free-ratio model is the best one
stands.
If we accept the free-ratio model as the best, this means
that there is evidence for positive selection acting in four
cases: 1) after the duplication that gave rise to the ancestor
of the UBQLNL group genes; 2) after the UBQLN1/
UBQLN2 duplication; 3) in the UBQLN3 genes after the
rat/human split and specifically in the lineage that gave
rise to humans; and, 4) in the UBQLNL genes, also in the
human lineage. However, given that the improvement of
the free-ratio model over the three-ratio model is not
highly significant, it cannot be disregarded at present that
positive selection may have acted solely on UBQLN3 and
UBQLNL, i. e. along branches 3 and 4 of Figure 10.
I finally performed branch-site models [63] to determine
whether any codon could be detected to be under positive
selection in branches 1, 2, 3 or 4 of Figure 10. Each branch
was examined in an independent analysis. However, per-
haps not unexpectedly, no significant results were found.
The most likely reason for those negative results is that
branch-site models only allow testing for positively se-
lected codons using two different ω values, one for a given
branch and a second for the rest of the tree. However, the
best model observed in branch models (free-ratio model)
implies a different ω value in each branch and it is thus
likely that the limitation of using just two of those values
for the whole tree precludes the determination of the co-
dons under positive selection. All PAML results can be
found in Additional file 3.
Discussion
This study establishes for the first time in the literature
the main patterns of the evolution of the ubiquilin gene
family. All the data obtained are compatible withubiquilins emerging very early in eukaryotic evolution
and transmitting strictly vertically. The only potential
exception found concerns the divergent ubiquilin de-
tected in the chytridiomycote Batrachochytrium dendro-
batidis, whose origin is uncertain. Very few ubiquilin
genes, most likely just a single one, were present before
the divergence of the main eukaryotic groups. Also, sin-
gle genes were most likely present in the ancestors of
animals, plants (including green algae) and fungi. Ubi-
quilin evolution has been in general very conservative,
given that most eukaryotes have just 1 – 2 ubiquilins.
The only exceptions are vertebrates and green plants, in
which up to 4 – 6 ubiquilins are detected in some spe-
cies. As already indicated, most plant duplications are
relatively recent, often genus-specific. Just a single an-
cient duplication must be postulated to explain the data
obtained for some monocots (poaceae) and a second
one for dicots. This explains why many viridiplantae spe-
cies have only 1 or 2 ubiquilin genes. Given that many
plant lineages have suffered whole genome duplications,
this means that ubiquilin genes are relatively “resistant”
to be duplicated in plants, i. e. many of the duplicates
have been lost. This is reminiscent of what is found in
some families of plant ubiquitin ligases [66,67]. At
present, the reason for the expansion of the ubiquilin
gene family in some plant lineages is totally unknown.
Respect to all the other groups, the amplification of
the ubiquilin gene family in vertebrates, and more spe-
cifically in mammals is clearly unique. Mammals have 5
– 6 ubiquilin genes, while most animal species (i. e. with
the only exception of Drosophila, all non-vertebrates, in-
cluding chordates, and also actinopterygian fish) have
just one. This multiplication has occurred recently. In
particular, four genes are not present in sauropsids and
three of them, UBQLN2, UBQLN3 and UBQLN5, are ap-
parently absent in monotremes, meaning that they may
have emerged in the last 150 millions of years. Losses of
ubiquilin genes in vertebrates have occurred, but only
rarely (Figure 4).
Genes of the UBQLN4 group (UBQLN1, UBQLN2 and
UBQLN4) have retained a general pattern of expression
which must be similar to that of the single ubiquilin
gene in other animals, which is most likely expressed in
all tissues (e. g. the Drosophila Ubqn results mentioned
above). There is good evidence for the products of
UBQLN4 group genes having roles as ubiquitin recep-
tors either to lead to proteasome degradation of ubiqui-
tinated proteins [7] or to redirect ubiquitinated proteins
to the autophagy pathway [68,69]. This second role is
not apparently performed by the Saccharomyces cerevi-
siae single ubiquilin, DSK2 [70]. An additional facet of
the role of these proteins is related to the finding that
UBQLN4 can interact with both UBQLN1 and UBQLN2,
and that this interaction redirects ubiquilin-interacting
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result suggests that the roles in autophagy may depend
on the presence of multiple different ubiquilins, and thus
would have appeared only after the duplications that
generated UBQLN1 and UBQLN2 from UBQLN4 [70].
This interesting functional hypothesis could be quite
simply tested, by determining whether ubiquilins have
roles in autophagy in actinopterygians fishes, in which
only UBQLN4 is present. Other important points that
deserve further study are: 1) why UBQLN4 has lower
levels of expression in all tissues than the other two
genes (Figures 6 and 7); 2) the cause of the increased
level of expression observed for these genes in particular
tissues, and especially in the nervous system (see also
Figures 6 and 7). This is a question that may provide
strong clues about their relationship with neurodegener-
ative diseases; 3) whether different UBQLN4 group pro-
teins have different affinities for different types of
ubiquitinated proteins or even for particular types of
ubiquitin chains, and, 4) whether there has been positive
selection on the UBQLN2 gene, as suggested by the
“free-ratio” model results (see above). It is noteworthy
the finding that yeast or plant ubiquilins show preferen-
tial binding to Lys-48 chains [71] while mammalian
UBQLN1 binds both Lys-48 and Lys-63 chains with
quite similar affinities [71,72]. Whether this difference is
related to the presence in mammals of multiple related
proteins of the UBQLN4 group, each with its own bio-
chemical properties, is unknown.
The testis-specific roles of the second trio, the UBQLNL
group genes UBQLN3, UBQLN5 and UBLQNL, have been
explored here in detail. A significant finding is that their
main roles seem to occur in spermatids, postmeiotic germ
cells (Figures 8 and 9). This may be used as a clue to
understand the origin of the UBQLNL group genes, which
cannot be deduced from the phylogenetic analyses, given
that none of the UBQLN4 group genes is particularly
similar to any of the UBQLNL group genes (Figure 3). I
think that it is significant that UBQLN1 is consistently
expressed in testis (Figures 6 and 7) while the levels of ex-
pression of UBQLN2 and UBQLN4 are much lower. Also,
it has been shown that UBQLN1 has specific roles in post-
meiotic germ cells, colocalizing with the manchette, a
structure made of actin and microtubules that is present
in elongating spermatids [61]. These results suggest that
the oldest UBQLNL group gene, UBQLNL, may have orig-
inated as a duplicate of UBQLN1.
It is likely that the production of testis-specific tandem
duplicates is linked to a strong selective pressure to in-
crease ubiquilin gene expression in that organ. In this
context, the fact that Drosophila CG31528, the only du-
plicate found in invertebrates (i. e. with an origin totally
independent from that of the UBQLNL group genes) is
also testis-specific seems to be more than a coincidentalfinding. It is also significant that some evidence for posi-
tive selection acting after the first UBQLNL group gene
originated but before the UBQLN3/UBQLNL duplication
occurred has been obtained (see “free-ratio” model re-
sults, above). The finding of positive selection acting on
the UBQLNL and UBQLN3 genes after the split that
separated rodents from primates, specifically in the hu-
man ancestors is quite robust (Figure 10), and also de-
serves further study.
Two alternative hypothesis for the origin of new testis-
specific ubiquilins are either that UBQLNL group genes
have acquired totally novel roles in that organ (neofunc-
tionalization) or that those genes have roles in the testis
that, before their emergence, were performed by other
ubiquilins, for example UBQLN1 (subfunctionalization).
At present, there is no way to determine which of these
options is correct, the precise roles of testis-specific ubi-
quilins being unknown. However, the fact that UBQLNL
group proteins are structurally different from their an-
cestors, having lost several Sti1 domains, suggests that
new functions may have arisen. In any case, this need
for an increase of ubiquilins in the testis must be related
to the important specific roles of the ubiquitination sys-
tem in the male gonad, for which there is a growing
body of evidence (see reviews: [73-75]). A recent work
has pointed out that perhaps 20 % of all ubiquitin li-
gases, which are the proteins that provide specificity
to the ubiquitination machinery, may be expressed at
much higher levels or even totally specifically in the
mouse testis [76]. The reasons for this particular need
for a complex, testis-specific ubiquitination machinery
are unknown. A hypothesis that fits well with the
data obtained in this study is that this specificity may
be linked to roles that are performed in male germ
cells, but not in somatic cells or female germ cells. In
this context, postmeiotic patterns of expression as
those found here for testis-specific ubiquilins are co-
incidental with those of genes critical for the substitu-
tion of histones by protamines, including transition
proteins and protamines themselves [77], suggesting
that they might be linked, directly or indirectly, to
this unique need for extreme chromatin compacta-
tion. However, other spermiogenesis-specific processes
(alteration of cell shape, generation of the acrosome
and flagellum, etc.; see [78]) are also candidates for
involving specific roles of the ubiquitin-proteasome in
which ubiquilins might be required.
Additional evolutionary considerations may contribute
to discriminate among these options. It is significant that
my own analyses of the data obtained by Hou et al. [76]
indicate that those testis-specific ubiquitin ligases
for which phylogenetic data is available (e. g. testis-
specifically expressed members of the RBR and TRIM
families that I have studied before [79,80]) originated at
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lished results). Therefore, the testis-specific roles of the
ubiquitination system proteins that we found now in
mouse or human may have arisen at very different times,
making unlikely a simple, all-encompassing explanation
for their functions. This means that we should look for
particular, gene-specific explanations, and then it be-
comes relevant exactly when each particular gene origi-
nated. Thus, the fact that group UBLQNL genes are
mammalian-specific, and two of them are found only in
eutherians, may provide important clues about their
roles. If we assume that their roles are linked to pro-
cesses that only happen in eutherians, we are left with
very few options, because most processes that occur in
the mammalian male germ line (e. g. the histone to pro-
tamine transition indicated above) have ancient origins,
being common to all vertebrates or even to all animals.
Actually, the available literature indicates that the main
functional differences between the male germ cells of
eutherian mammals and those of reptiles, birds or even
monotremes are related to the difficulty to fecundate the
heavily protected eutherian oocytes (reviewed in
[81,82]). Eutherian sperm has acquired a series of spe-
cific adaptations to achieve fecundation, involving redis-
tribution of products through complex intracellular
transport processes that lead to changes both in the
physiology and the shape of the cells [83,84]. These spe-
cific adaptations are good candidates to require proteins
with novel roles. Given that the product of UBQLN1 –
probably the ancestral gene from which the testis-
specific ubiquilins emerged and also the only one among
the UBQLN4 group genes consistently expressed in the
testis – colocalizes with the manchette [61], a structure
linked to intracellular transport in these germ cells, an
attractive hypothesis is that the emergence of the
UBQLNL group proteins is related to new roles of the
ubiquitination system linked to these eutherian-specific
sperm adaptations. This hypothesis can be tested by gen-
erating loss-of-function mutants in the testis-specific
ubiquilin genes.
Conclusions
The ubiquilin gene family is present in all eukaryotes
and has a very conservative pattern of evolution, with
many eukaryotic species having a single gene. The
lineage-specific amplifications observed, among which
the one detected in mammals is the most extensive, are
probably linked to the acquisition of specific, potentially
novel functions by the newly-emerged duplicates. In
mammals, three recently arisen ubiquilins are required
specifically in the testis and this is also the case for a
Drosophila novel ubiquilin gene. This suggests that du-
plications leading to the generation of genes with testis-
specific roles may occasionally provide a selectiveadvantage in animal lineages. Potential roles in intracel-
lular transport for the mammalian testis-specific pro-
teins are suggested by the available data.
Methods
Ubiquilin sequences were obtained by TblastN searches
against the nr, est, htgs, gss, wgs and tsa databases at the
National Center for Biotechnology Information (NCBI;
http://www.ncbi.nlm.nih.gov/). First, general searches
and then specific searches to detect ubiquilins of par-
ticular groups (animal, plants, fungi, etc.) or critical
model species which could have been missed in the ori-
ginal searches were performed. The query sequences for
those searches were selected from all main eukaryotic
groups in which ubiquitins were detected (animals,
plants, fungi, amoebozoans, alveolates and flagellates).
Given the high similarity among all ubiquilins, those
searches soon became saturated, with no additional se-
quences being detectable when additional query se-
quences were used.
From those searches, and after eliminating duplicates
and partial sequences, a total of 643 sequences were
found to be complete or almost complete (i. e. only
missing a few amino acids, generally at the N or C ter-
mini). A total of 619 of them had full-length UBA and
UBL domains. These sequences were aligned using
MAFFT v6.864b [85] and the alignments were manually
corrected editing the sequences with GeneDoc 2.7 [86].
Phylogenetic analyses were performed following similar
procedures to those in several studies focused on ubiqui-
tination system genes ([87,88] and related references
along the text). Three different methods were used,
namely Neighbor-joining (NJ), maximum-parsimony
(MP) and maximum-likelihood (ML). NJ and ML trees
were obtained using MEGA 5.1 [89] and Maximum-
parsimony (MP) trees were obtained using PAUP* 4.0,
beta 10 version [90]. For NJ, Kimura´s correction was
used and sites with gaps were treated with the pairwise
deletion option. Parameters for MP analyses based on
full-length sequences were as follows: 1) all sites in-
cluded, gaps treated as unknown characters; 2) randomly
generated trees used as seeds; 3) maximum number of
trees saved equal to 100; and, 4) heuristic search using
the tree-bisection-reconnection (TBR) algorithm, with
default parameters. The same methods were used for
analyses of alignments of the UBA and UBL domains,
except that the faster subtree-pruning-regrafting (SPR)
algorithm, also with default parameters, was used instead
of the TBR algorithm. The reason for this methodo-
logical change is that the analyses based on UBA and
UBL domains included a very large number of se-
quences, making TBR-based analyses unfeasible. Finally,
for ML analyses, the BioNJ tree was taken as starting
point for the iterative searches using the Jones-Taylor-
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discrete Gamma (G) distribution with five categories of
sites was estimated, to account for heterogeneity in evo-
lutionary rates. This JTT + G model was chosen because
it was the best, according to the ML model comparison
analyses available in MEGA 5.1. Gaps were also treated
as unknown characters. Here, for the same reason indi-
cated above, while the TBR routine with 3 levels of tree
interchange was used to explore the landscape of ML
trees in analyses involving full-length sequences, the fas-
ter SPR algorithm, also with 3 levels of subtree inter-
change, was used in the analyses involving just the UBA
and UBL domains. Bootstrap tests were performed to es-
tablish the reliability of the final dendrograms obtained
in the NJ, MP and ML analyses. A total of 1000 repli-
cates were generated for NJ analyses and 100 replicates
were made for the MP and ML analyses, which are more
computer-intensive. MEGA 5.1 was also used to draw
and edit the trees in Figures 1, 2, 3, 4 and 5.
The origin of the genes and the patterns of duplica-
tions and losses were determined by reconciling the gene
trees with the species trees and, when needed, integrat-
ing additional information such as the relative location
of the genes in several genomes, which ones are the
genes located adjacent to those encoding ubiquilins or
the ubiquilin protein structures (see Results for the de-
tails). Analyses of the genomic locations of ubiquilin
genes were performed at the Ensembl genome browser
web page [91] (http://www.ensembl.org/). Structural
analyses of the ubiquilin proteins were performed using
the integrated tool InterProScan [92] (available online at
http://www.ebi.ac.uk/Tools/pfa/iprscan/).
Microarray data were obtained from the public reposi-
tories in which the datasets from the studies cited along
the text were deposited. These were either the Gene
Expression Omnibus (GEO) database at the NCBI (http://
www.ncbi.nlm.nih.gov/geo/), the ArrayExpress database
(http://www.ebi.ac.uk/arrayexpress/) or the BioGPS data-
base (http://www.biogps.org). For some samples and
genes, multiple probes or experiments were available. In
those cases, I chose the ones with the highest average level
of expression. The raw data of the experiments has been
used in this study. Given that the quantitative values of ex-
pression of different experiments were not compared, no
further normalization or other kinds of data manipulation
were required.
Analyses to detect positive selection in human ubiqui-
lins were performed using PAMLX [65], a graphical
interface for the PAML program [63]. Methods were
very similar to those described in one of my previous pa-
pers [64]. In brief, I took the protein sequences of the
full-length UBA and UBL domains (a total of 117 amino
acids) of the five ubiquilin genes present in both Homo
sapiens and Rattus norvegicus (UBQLN1, UBQLN2,UBQLN3, UBQLN4 and UBQLNL) and obtained the cor-
responding nucleotide sequences for those regions of the
genes in the two species. Trees were obtained with the
ten sequences that generated the expected topology
(Figure 10). Then, the codon-substitution models imple-
mented in the CODEML program of PAML [63] were
used to estimate the synonymous (dS) and non-
synonymous (dN) rates of evolution, in order to deter-
mine: 1) whether positive selection (ω = dN/dS > 1) was
detectable at some codons in the whole sets of se-
quences (“site models”); 2) whether positive selection
was detected in particular branches of the sequences tree
(“branch models”); and, 3) whether positive selection
was detectable at some codons in particular branches of
the trees (“branch-site models”) [63,64]. The CODEML
analyses provide the log likelihood value of a given
model of codon substitution, for the sequences consid-
ered and evaluating their evolutionary relationships. All
the comparisons made here among alternative models
corresponded to pairs of nested models. Thus, their re-
sults can be compared by using the LRT statistic. This
statistic equals 2 Δl, being Δl the difference between the
log likelihoods of the two models. The LRT statistic fol-
lows a chi-square distribution with a number of degrees
of freedom equal to the difference in the number of pa-
rameters used in each of the two models that are com-
pared (see details in [63,64] and references therein).
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